IBD mucosal cells express reduced levels of SIRT1, a class III NAD+-dependent deacetylase, which inhibits the expression of various proteins involved in the control of immune-inflammatory pathways, such as STAT3, Smad7, and NF-κB. Here, NFKB1 is linked to inflammatory bowel disease.